GEMCITABINE, OXALIPLATIN AND CAPECITABINE (GEMOXEL) FOR PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA (APC). PRELIMINARY RESULTS OF AN ONGOING PHASE I/II TRIAL

被引:0
|
作者
Hess, V. [1 ]
Pestalozzi, B. [2 ]
Ludwig, C. [3 ]
Winterhalder, R. [4 ]
Lohri, A. [5 ]
Jost, L. [6 ]
Widmer, L. [7 ]
Lee, L. [1 ]
Stillhart, P. [1 ]
Herrmann, R. [1 ]
机构
[1] Univ Basel Hosp, CH-4031 Basel, Switzerland
[2] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[3] St Clara Hosp, Basel, Switzerland
[4] Kantonsspital Luzern, Luzern, Switzerland
[5] Kantonsspital Liestal, CH-4410 Liestal, Switzerland
[6] Kantonsspital Bruderholz, Bruderholz, Switzerland
[7] Onkozentrum Hirslanden, Zurich, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:181 / 181
页数:1
相关论文
共 50 条
  • [1] Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial
    Hess, V.
    Pratsch, S.
    Potthast, S.
    Lee, L.
    Winterhalder, R.
    Widmer, L.
    Cescato, C.
    Lohri, A.
    Jost, L.
    Stillhart, P.
    Pestalozzi, B.
    Herrmann, R.
    ANNALS OF ONCOLOGY, 2010, 21 (12) : 2390 - 2395
  • [2] A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma
    Byeong-Bae Park
    Joon Oh Park
    Hyo Rak Lee
    Jeeyun Lee
    Dong Wook Choi
    Seong-Ho Choi
    Jin Seok Heo
    Jong Kyun Lee
    Kyu Taek Lee
    Do Hoon Lim
    Young Suk Park
    Ho-Yeong Lim
    Won Ki Kang
    Keunchil Park
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 489 - 494
  • [3] A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma
    Park, Byeong-Bae
    Park, Joon Oh
    Lee, Hyo Rak
    Lee, Jeeyun
    Choi, Dong Wook
    Choi, Seong-Ho
    Heo, Jin Seok
    Lee, Jong Kyun
    Lee, Kyu Taek
    Lim, Do Hoon
    Park, Young Suk
    Lim, Ho-Yeong
    Kang, Won Ki
    Park, Keunchil
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 489 - 494
  • [4] Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
    Roberto Petrioli
    Giandomenico Roviello
    Anna Ida Fiaschi
    Letizia Laera
    Daniele Marrelli
    Franco Roviello
    Edoardo Francini
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 683 - 690
  • [5] Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
    Petrioli, Roberto
    Roviello, Giandomenico
    Fiaschi, Anna Ida
    Laera, Letizia
    Marrelli, Daniele
    Roviello, Franco
    Francini, Edoardo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 683 - 690
  • [6] Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: A phase I/II trial
    Hess, V
    Salzberg, M
    Borner, M
    Morant, R
    Roth, AD
    Ludwig, C
    Herrmann, R
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) : 66 - 68
  • [7] Phase II trial of bevacizumab, gemcitabine, oxaliplatin in patients with metastatic pancreatic adenocarcinoma
    Kim, G. P.
    Oberg, A. L.
    Foster, N. R.
    Jaslowski, A.
    Flynn, P. J.
    Campbell, D.
    Hedrick, E.
    Gray, L.
    Grothey, A.
    Alberts, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer
    Choi, Jong Gwon
    Seo, Jae Hong
    Oh, Sang Cheul
    Choi, Chul Won
    Kim, Jun Suk
    CANCER RESEARCH AND TREATMENT, 2012, 44 (02): : 127 - 132
  • [9] Preliminary results of phase II trial with combination of gemcitabine and oxaliplatin in elderly patients with advanced NSCLC.
    Buosi, R
    Poletti, S
    Cantele, V
    Piazza, S
    Torazzo, R
    Negru, E
    Vandone, A
    Alabiso, O
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 703S - 703S
  • [10] Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma - Results of a phase II trial
    Dragovich, Tomislav
    Burris, Howard, III
    Loehrer, Patrick
    Von Hoff, Daniel D.
    Chow, Sherry
    Stratton, Steven
    Green, Sylvan
    Obregon, Yrma
    Alvarez, Irene
    Gordon, Michael
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (02): : 157 - 162